RTOG -1012

Trial

Clinical Trial Title

RTOG -1012

Trial Status

Open to Enrollment

Start Date

September 6, 2013

Location

Trial Type

Cancer (Oncology)

Specific Condition

Lung Cancer

Description

Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer

Eligibility Criteria

Patients being treated with combination chemotherapy (definitive or adjuvant) and radiation therapy once daily for small cell or non-small cell lung cancer; at least 5 cm of the esophagus must be in the 60 Gy isodose volume.

Patients must be ≥ 18 years of age

Patients must be able to swallow thick liquids during treatment

Patients must not have a known hypersensitivity to honey

Patients must not have metastatic disease?

 

 

IRB Number

Legacy IRB

Notes

Sponsored by: RTOG Radiation Therapy Oncology Group

Principal Investigator Name

Andrew Kee, MD

Contact Name

Legacy Oncology Clinical Research

Phone

503-413-8199

Contact Fax

503-413-6920

Last Updated: Wednesday, September 18, 2013 01:40:18 PM

We'd like to make your experience better.
x

Help us improve our site and be entered to win a $100 gift card.

Take the Survey